The content is available as a PDF (484.9 KB).
Footnotes
The authors had no financial or other conflicts of interest to disclose.
editorial . 2006 Mar 8;10(5):257–258. doi: 10.2310/7060.2003.2669
Confronting the New Challenge in Travel Medicine: SARS
Annelies Wilder-Smith
1,2,✉, David O Freedman
1,2
Annelies Wilder-Smith
1
Annelies Wilder-Smith, MD, MIH, PhD: Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
2
Professor David O. Freedman, MD: Division of Geographic Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Find articles by Annelies Wilder-Smith
David O Freedman
1
Annelies Wilder-Smith, MD, MIH, PhD: Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
2
Professor David O. Freedman, MD: Division of Geographic Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Find articles by David O Freedman
1
Annelies Wilder-Smith, MD, MIH, PhD: Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
2
Professor David O. Freedman, MD: Division of Geographic Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
✉
Reprint requests: Dr A. Wilder-Smith, Head, Travellers' Health and Vaccination Centre, Department of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
Collection date 2003 Oct 1.
© 2003 International Society of Travel Medicine
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7107584 PMID: 14531976